Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
Factors affecting use of magnesium sulphate for pre-eclampsia or eclampsia: a qualitative evidence synthesis.
复制标题
DOI：
10.1111/1471-0528.16913
复制
发表时间：
2022-03
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
高血压疾病占全球孕产妇死亡的14%。硫酸镁（MgSO4）被推荐用于预防和治疗子痫前期/子痫。然而，硫酸镁仍未得到充分利用，特别是在低收入和中等收入国家（LMICs）。本定性证据综合探讨了医疗保健提供者、管理人员和政策制定者对影响使用MgSO4预防或治疗先兆子痫/子痫的因素的看法和经验。我们检索了MEDLINE、EMBASE、Emcare、CINAHL、Global Health和Global Index Medicus以及1995年1月至2021年6月间发表的灰色文献。从医疗保健提供者、管理人员和政策制定者的角度，对医疗保健环境中影响MgSO4使用的因素进行了初步定性和混合方法研究，符合纳入条件。我们采用主题综合方法进行分析，使用COM - B行为变化理论来绘制影响MgSO4适当使用的因素。我们纳入了22项研究，主要来自中低收入国家。关键主题包括提供者管理MgSO4的能力和信心（态度和信念，管理的复杂性，知识和经验），卫生系统确保使用点MgSO4可用性的能力（可用性，资源和护理途径）和知识翻译（研究和建议的传播）。在每个COM - B域内，我们绘制了生理和心理能力、生理和社会机会的促进因素和障碍，以及这些域之间的相互作用如何影响动机。这些发现可以为政策和指南的制定提供信息，并改善临床护理中MgSO4的实施。需要采取这样的行动，以确保这种挽救生命的治疗得到广泛提供和适当使用。全球定性回顾确定了影响MgSO4在子痫前期和子痫中应用不足的因素。全球定性回顾确定了影响MgSO4在子痫前期和子痫中应用不足的因素。这篇文章包括作者的见解，一个视频摘要可以在https://vimeo.com/manage/videos/623192027链接文章这篇文章由LA Magee评论，第392页在这个问题上。要查看这个迷你评论，请访问https://doi.org/10.1111/1471-0528.16971。
Hypertensive disorders account for 14% of global maternal deaths. Magnesium sulphate (MgSO4) is recommended for prevention and treatment of pre‐eclampsia/eclampsia. However, MgSO4 remains underused, particularly in low‐ and middle‐income countries (LMICs). This qualitative evidence synthesis explores perceptions and experiences of healthcare providers, administrators and policy‐makers regarding factors affecting use of MgSO4 to prevent or treat pre‐eclampsia/eclampsia. We searched MEDLINE, EMBASE, Emcare, CINAHL, Global Health and Global Index Medicus, and grey literature for studies published between January 1995 and June 2021. Primary qualitative and mixed‐methods studies on factors affecting use of MgSO4 in healthcare settings, from the perspectives of healthcare providers, administrators and policy‐makers, were eligible for inclusion. We applied a thematic synthesis approach to analysis, using COM‐B behaviour change theory to map factors affecting appropriate use of MgSO4. We included 22 studies, predominantly from LMICs. Key themes included provider competence and confidence administering MgSO4 (attitudes and beliefs, complexities of administering, knowledge and experience), capability of health systems to ensure MgSO4 availability at point of use (availability, resourcing and pathways to care) and knowledge translation (dissemination of research and recommendations). Within each COM‐B domain, we mapped facilitators and barriers to physical and psychological capability, physical and social opportunity, and how the interplay between these domains influences motivation. These findings can inform policy and guideline development and improve implementation of MgSO4 in clinical care. Such action is needed to ensure this life‐saving treatment is widely available and appropriately used. Global qualitative review identifies factors affecting underutilisation of MgSO4 for pre‐eclampsia and eclampsia. Global qualitative review identifies factors affecting underutilisation of MgSO4 for pre‐eclampsia and eclampsia. This article includes Author Insights, a video abstract available at https://vimeo.com/manage/videos/623192027 Linked article This article is commented on by LA Magee, p. 392 in this issue. To view this mini commentary visit https://doi.org/10.1111/1471-0528.16971.
影响因子：
1.8
作者：
Okereke E;Ahonsi B;Tukur J;Ishaku SM;Oginni AB
通讯作者：
Oginni AB